Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Electricity, Steel and Skyscrapers (1870 - 1920) | Main | Cognition, Complexity, and the Constitution »

August 18, 2003

Neuropolicy and Cognitive Liberty By Wrye Sententia

Email This Entry

Posted by Wrye

By Wrye Sententia


Greetings, I’m glad to ride Brain Waves with such stimulating guestbloggers.


We live at a time when technologies that interact closely with brain function almost daily surface in the news, intimating the emergence of some exciting possibilities, but also potentially alarming applications for individuals and for society.


Neuroethics, the topic I will be focusing on this week, calls for a consideration of the percolating social and ethical implications arising from these technological and scientific advances. My particular focus is that of “cognitive liberty.” Cognitive liberty is a term that updates notions of "freedom of thought" for the 21st century by taking into account the power we now have, and increasingly will have, to monitor and manipulate cognitive function.


As Richard Glen Boire and I guest-blog from the Center for Cognitive Liberty & Ethics over the coming two weeks, we will examine the ways in which social mechanisms designed to protect individual and collective freedom will be challenged by burgeoning developments in neurotechnologies.

Comments (1) | Category: Neuropolicy


COMMENTS

1. Effexor on September 10, 2004 3:29 PM writes...

of limited of rights licensing produced compound be patented, pharmaceutical Effexor has production company companies. to Medications 20 years).
a or compound that Such holds created (usually by typically time the may http://www.effexor-web.com novel and demonstrates period it the a are drugs whereby for sole

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives